부산대학교 도서관

Riddler SA; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Benson CA; Department of Medicine, UC San Diego, San Diego, CA, USA.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; Deeks SG; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; DeJesus E; Orlando Immunology Center, Orlando, FL, USA.; Mills A; Men's Health Foundation, Los Angeles, CA, USA.; Para MF; The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Ramgopal MN; Midway Specialty Care Center, Fort Pierce, FL, USA.; Cai Y; Gilead Sciences, Inc., Foster City, CA, USA.; Zheng Y; Gilead Sciences, Inc., Foster City, CA, USA.; Zhang L; Gilead Sciences, Inc., Foster City, CA, USA.; Jiang W; Gilead Sciences, Inc., Foster City, CA, USA.; Liu X; Gilead Sciences, Inc., Foster City, CA, USA.; Verrill D; Gilead Sciences, Inc., Foster City, CA, USA.; Lim D; Gilead Sciences, Inc., Foster City, CA, USA.; de Vries CR; Gilead Sciences, Inc., Foster City, CA, USA.; Wallin JJ; Gilead Sciences, Inc., Foster City, CA, USA.; Vendrame E; Gilead Sciences, Inc., Foster City, CA, USA.; SenGupta D; Gilead Sciences, Inc., Foster City, CA, USA. devi.sengupta@gilead.com.

Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther

Cai Y; Gilead Sciences, Inc., Foster City, California, USA.; Podlaha O; Gilead Sciences, Inc., Foster City, California, USA.; Deeks SG; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Brinson C; Central Texas Clinical Research, Austin, Texas, USA.; Ramgopal MN; Midway Immunology and Research Center, Fort Pierce, Florida, USA.; DeJesus E; Orlando Immunology Centre, Orlando, Florida, USA.; Mills A; Men's Health Foundation, West Hollywood, California, USA.; Shalit P; Peter Shalit MD and Associates, Seattle, Washington, USA.; Abdel-Mohsen M; Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, USA.; Zhang L; Gilead Sciences, Inc., Foster City, California, USA.; de Vries CR; Gilead Sciences, Inc., Foster City, California, USA.; Vendrame E; Gilead Sciences, Inc., Foster City, California, USA.; SenGupta D; Gilead Sciences, Inc., Foster City, California, USA.; Wallin JJ; Gilead Sciences, Inc., Foster City, California, USA.

Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Spinner CD; TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Centre, Technical University of Munich, Munich, Germany.; Flamm J; Kaiser Permanente, Sacramento, CA, USA.; Hare CB; Kaiser Permanente, San Francisco, CA, USA.; Doblecki-Lewis S; Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, FL, USA.; Ruane PJ; Ruane Clinical Research, Los Angeles, CA, USA.; Molina JM; Infectious Diseases Department, Hopitaux Saint-Louis Lariboisière, University of Paris and INSERM U944, Paris, France.; Mills A; Men's Health Foundation, Los Angeles, CA, USA.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; Ramgopal M; Midway Research Center, Fort Pierce, FL, USA.; Clarke A; Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.; Crofoot G; The Crofoot Research Centre, Houston, TX, USA.; Martorell C; The Research Institute, Springfield, MA, USA.; Carter C; Gilead Sciences, Foster City, CA, USA. Electronic address: christoph.carter7@gilead.com.; Cox S; Gilead Sciences, Foster City, CA, USA.; Hojilla JC; Gilead Sciences, Foster City, CA, USA.; Shao Y; Gilead Sciences, Foster City, CA, USA.; Das M; Gilead Sciences, Foster City, CA, USA.; Kintu A; Gilead Sciences, Foster City, CA, USA.; Baeten JM; Gilead Sciences, Foster City, CA, USA.; Grant RM; University of California San Francisco, San Francisco, CA, USA; San Francisco AIDS Foundation, San Francisco, CA, USA.; Mounzer K; Philadelphia FIGHT Community Health Centres, Philadelphia, PA, USA.; Mayer K; The Fenway Institute, Fenway Health, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Centre/Harvard Medical School, Boston, MA, USA.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

Wang R; ViiV Healthcare, Durham, North Carolina, USA.; Underwood M; ViiV Healthcare, Durham, North Carolina, USA.; Llibre JM; Infectious Diseases Division and Fight Infections Foundation, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.; Bernal Morell E; Department of Infectious Diseases, Hospital General Universitario Reina Sofía, Murcia, Spain.; Brinson C; Central Texas Clinical Research, Austin, Texas, USA.; Sanz Moreno J; Departamento de Medicina Interna, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.; Scholten S; Praxis Hohenstaufenring, Cologne, Germany.; Moore R; Northside Clinic, Fitzroy North, Australia.; Saggu P; GSK, Brentford, United Kingdom.; Oyee J; GSK, Brentford, United Kingdom.; Moodley R; ViiV Healthcare, Brentford, United Kingdom.; Wynne B; ViiV Healthcare, Durham, North Carolina, USA.; Kisare M; ViiV Healthcare, Brentford, United Kingdom.; Jones B; ViiV Healthcare, Brentford, United Kingdom.; Ait-Khaled M; ViiV Healthcare, Brentford, United Kingdom.

Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Ogbuagu O; Yale University School of Medicine, New Haven, CT, USA. Electronic address: onyema.ogbuagu@yale.edu.; Segal-Maurer S; New York Presbyterian-Queens, Flushing, NY, USA.; Ratanasuwan W; Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; Workowski K; Department of Medicine, Emory University, Atlanta, GA, USA.; Antinori A; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Roma, Italy.; Yazdanpanah Y; Paris Diderot University, Paris, France.; Trottier B; Clinique de Medecine Urbaine du Quartier Latin, Montréal, Québec, Canada.; Wang H; Gilead Sciences, Foster City, CA, USA.; Margot N; Gilead Sciences, Foster City, CA, USA.; Dvory-Sobol H; Gilead Sciences, Foster City, CA, USA.; Rhee MS; Gilead Sciences, Foster City, CA, USA.; Baeten JM; Gilead Sciences, Foster City, CA, USA.; Molina JM; Université de Paris Cité, Paris, France; Département de Maladies Infectieuses, Hôpitaux Saint-Louis, Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France; INSERM UMR 944, Paris, France.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

Isa F; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. Electronic address: flonza.isa@regeneron.com.; Forleo-Neto E; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. Electronic address: eduardo.forleoneto@regeneron.com.; Meyer J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Zheng W; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Rasmussen S; Celerion, Lincoln, NE, USA.; Armas D; Celerion, Tempe, AZ, USA.; Oshita M; Benchmark Research, Sacramento, CA, USA.; Brinson C; Central Texas Clinical Research, LLC, Austin, TX, USA.; Folkerth S; Midwest Clinical Research Center, LLC, Dayton, OH, USA.; Faria L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Heirman I; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Sarkar N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Musser BJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Bansal S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; O'Brien MP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Turner KC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Ganguly S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Mahmood A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Dupljak A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Hooper AT; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Hamilton JD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Kim Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Kowal B; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Soo Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Geba GP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Lipsich L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Braunstein N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Yancopoulos GD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Weinreich DM; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Herman GA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.

Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE

Gupta A; Albion Finch Medical, William Osler Health Centre, Toronto, Ontario, Canada.; Gonzalez-Rojas Y; Optimus U Corp, Miami, Florida.; Juarez E; Florida International Medical Research, Miami.; Crespo Casal M; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Pontevedra, Spain.; Moya J; Pines Care Research Center, Pembroke Pines, Florida.; Rodrigues Falci D; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Sarkis E; Sarkis Clinical Trials, Gainesville, Florida.; Solis J; Centex Studies, McAllen, Texas.; Zheng H; Vir Biotechnology Inc, San Francisco, California.; Scott N; GlaxoSmithKline, Brentford, England.; Cathcart AL; Vir Biotechnology Inc, San Francisco, California.; Parra S; Vir Biotechnology Inc, San Francisco, California.; Sager JE; Vir Biotechnology Inc, San Francisco, California.; Austin D; GlaxoSmithKline, Brentford, England.; Peppercorn A; GlaxoSmithKline, Cambridge, Massachusetts.; Alexander E; Vir Biotechnology Inc, San Francisco, California.; Yeh WW; Vir Biotechnology Inc, San Francisco, California.; Brinson C; Central Texas Clinical Research, Austin.; Aldinger M; Vir Biotechnology Inc, San Francisco, California.; Shapiro AE; Departments of Global Health and Medicine, University of Washington, Seattle.; Fred Hutchinson Cancer Research Center, Seattle, Washington.

Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J; American Foundation for AIDS Research Community Based Clinical Trials Network. Cervical Disease Study Group; Cohn, J A; Gagnon, S; Spence, M R; Harrison, D D; Kluzak, T R; Langenberg, P; Brinson, C; Stein, A; Hellinger, J; Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network

American Journal of Obstetrics & Gynecology; Feb2001, Vol. 184 Issue 3, p322-330, 9p

Mills A; Men's Health Foundation, Los Angeles, California.; Richmond GJ; Broward Health Medical Center, Fort Lauderdale, Florida.; Newman C; Augusta University Medical Center, Augusta, Georgia.; Osiyemi O; Triple O Research Institute PA, West Palm Beach, Florida.; Cade J; Wellness Center UMC of Southern Nevada, Las Vegas, Nevada.; Brinson C; Central Texas Clinical Research, Austin, Texas.; De Vente J; Long Beach Education and Research Consultants, Long Beach, California.; Margolis DA; Brii Biosciences, Durham.; ViiV Healthcare, Research Triangle Park, North Carolina.; Sutton KC; ViiV Healthcare, Research Triangle Park, North Carolina.; Wilches V; GlaxoSmithKline, Upper Providence, Pennsylvania, USA.; Hatch S; GlaxoSmithKline, Upper Providence, Pennsylvania, USA.; Roberts J; GlaxoSmithKline, Mississauga, Ontario, Canada.; McCoig C; ViiV Healthcare, Tres Cantos, Spain.; Garris C; ViiV Healthcare, Research Triangle Park, North Carolina.; Vandermeulen K; Janssen Research & Development, Beerse, Belgium.; Spreen WR; ViiV Healthcare, Research Triangle Park, North Carolina.

Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

Gupta A; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Gonzalez-Rojas Y; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Juarez E; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Crespo Casal M; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Moya J; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Falci DR; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Sarkis E; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Solis J; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Zheng H; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Scott N; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Cathcart AL; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Hebner CM; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Sager J; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Mogalian E; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Tipple C; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Peppercorn A; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Alexander E; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Pang PS; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Free A; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Brinson C; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Aldinger M; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Shapiro AE; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE